Table 1.
First position of binder | Sequence | ALLELE: HLA | Cell line |
---|---|---|---|
168 | EIEPAAMKA | A1 | KNUD |
617 | NSEEDAKAA | ||
481 | SGESKTLVL | ||
95 | KTVTPAKAV | A2 | Ma-Mel-12 |
522 | KGYAFIEFA | Ma-Mel-04 | |
300 | TEPTTAFNL | ||
223 | VVPVKAKNV | ||
223 | VVPVKAKNV | A*0201 | WM115 |
63 | VVVSPTKKV | ||
522 | KGYAFIEFA | ||
95 | KTVTPAKAV | ||
493 | SYSATEETL | A24 | Ma-Mel-27 |
314 | NFNKSAPEL | Ma-Mel-8b | |
355 | SAEDLEKAL | ||
109 | KGATPGKAL | ||
391 | ARTLLAKNL | B14 | Ma-Mel-8b |
318 | SAPELKTGI | B*3501 | Ma-Mel-8b |
170 | EPAAMKAAA | Ma-Mel-12 | |
109 | KGATPGKAL | ||
75 | TPAKKAAVT | ||
632 | GEIDGNKVT | B*4403 | WM115 |
281 | KEMAKQKAA | KNUD | |
300 | TEPTTAFNL | ||
169 | IEPAAMKAA | ||
281 | KEMAKQKAA | B61 | Ma-Mel-27 |
297 | VEGTEPTTA | ||
169 | IEPAAMKAA | ||
632 | GEIDGNKVT | ||
407 | ELKEVFEDA | B62 | Ma-Mel-27 |
109 | KGATPGKAL | B7 | Ma-Mel-04 |
Ma-Mel-12 | |||
216 | KGKKAAKVV | B*0702 | Ma-Mel-04 |
281 | KEMAKQKAA | Ma-Mel-12 | |
122 | GKKGAAIPA | ||
95 | KTVTPAKAV | ||
357 | EDLEKALEL | Cw*0301 | Ma-Mel-12 |
351 | VDFESAEDL | ||
493 | SYSATEETL | Cw*0401 | Ma-Mel-12 |
314 | NFNKSAPEL | ||
479 | TWSGESKTL | ||
391 | ARTLLAKNL | Cw*0602 | WM115 |
355 | SAEDLEKAL | Ma-Mel-12 |
N potential N-glycosylation sites, T potential O-glycosylation sites
The alleles of MHC class-I present on analysed cell lines: KNUD, Ma-Mel-04, Ma-Mel-8b, Ma-Mel-12, Ma-Mel-16, Ma-Mel-27 and WM115 were taken into consideration. All peptides having score greater than threshold score at 4% were considered as predicted binders for selected MHC alleles